The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...

Enigma Biomedical USA Inc. has selected two four-repeat tau (4R tau) protein PET imaging biomarkers to advance into phase I studies. These imaging biomarkers show promise as important new tools in ...

Table of Contents Transforming Treatment Approaches From Lab Discovery to Clinical Impact Paper Summary In a nutshell A new ...

Enigma Biomedical USA, Inc. ( EB USA) today announced that it is starting a collaboration with the Boston University Chronic Traumatic Encephalopathy (CTE) Center and the Concussion Legacy Foundation.

In vivo imaging of tau pathology by PET will allow new insights into tau deposition in the human brain, facilitating research into causes, diagnosis and treatment of major neurodegenerative ...

This collaboration will focus on demonstrating the value of 4R Tau PET imaging biomarkers in advancing our understanding of CTE. The initial aspects of the CTE partnership will involve ...